Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort Study

BACKGROUND: The value of coronary artery calcium (CAC) in the allocation of PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitors) among individuals without clinically evident atherosclerotic cardiovascular disease (ASCVD) is unknown for indications that do not require confirmed familial...

Descripción completa

Detalles Bibliográficos
Autores principales: Cainzos‐Achirica, Miguel, Quispe, Renato, Mszar, Reed, Dudum, Ramzi, Al Rifai, Mahmoud, Erbel, Raimund, Stang, Andreas, Jöckel, Karl‐Heinz, Lehmann, Nils, Schramm, Sara, Schmidt, Börge, Toth, Peter P., Rana, Jamal S., Lima, Joao A. C., Doria de Vasconcellos, Henrique, Lloyd‐Jones, Donald, Joshi, Parag H., Ayers, Colby, Khera, Amit, Blaha, Michael J., Greenland, Philip, Nasir, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496288/
https://www.ncbi.nlm.nih.gov/pubmed/35943062
http://dx.doi.org/10.1161/JAHA.122.025737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496288/
https://www.ncbi.nlm.nih.gov/pubmed/35943062
http://dx.doi.org/10.1161/JAHA.122.025737

Ejemplares similares